What We Do
CONRAD pioneered the development of microbicides for HIV prevention and multipurpose prevention technologies that combine drugs with several mechanisms of action that provide contraception and HIV prevention. As such, our capabilities include developing and evaluating new products, methods and testing methodologies to late-stage development and market, including regulatory submissions. Our success starts with a group of individuals who have significant expertise in product development, preclinical studies, regulatory affairs, clinical trial development and execution. Our proven track record of collaboration with diverse institutions ranging from governmental to private, domestic to international, and pharmaceutical to academic has enabled us to lead the field of reproductive health innovation.
Focus: Development of new, safe and effective microbicides, contraceptives, and multipurpose prevention technologies